Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine vs compound glycyrrhizin in oral lichen planus with diabetes
ChiCTR-IPR-17010622Phase 4Recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Mar 2017
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in oral lichen planus (OLP) and type 2 diabetes mellitus (T2DM) comparing hydroxychloroquine group with compound glycyrrhizin group (2 arms). Primary endpoint: glycosylated hemoglobin. Started Mar 2017; status: recruiting.
02
Drugs
hydroxychloroquineglycyrrhizinate
03
Conditions
oral lichen planus (OLP)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-IPR-17010622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010622.